GHTC statement in advance of the World Health Organization (WHO) inaugural forum with non-state actors.
Learn more
GHTC submitted testimony for the public record for a hearing held April 16, 2021 by the House Foreign Affairs Subcommittee on International Organizations and Global Corporate Social Impact titled Innovation in Development Policy: Maximizing Impact and Results.
PDF
GHTC joined letters from the Global Health Council Maternal and Child Health Roundtable to House and Senate Appropriators encouraging robust funding for fiscal year 20211 (FY22) for maternal and child heath and nutrition accounts at the US Agency for International Development.
PDF
Health Policy Watch featured a commentary from GHTC Director Jamie Bay Nishi outlining six steps for the US government to pivot from the pandemic to a golden era of global health R&D.
View
As the G20 Health Working Group meets next this Thursday and Friday, GHTC urges them to prioritize several actions to bolster R&D to defeat COVID-19, mitigate its impacts, and combat other long-standing and emerging threats.
Learn more
GHTC's policy report Meeting the moment, fueling the future: Policy recommendations for a new era of leadership in global health R&D was featured in a news story on LaboratoryEquipment.com.
View
GHTC's policy report Meeting the moment, fueling the future: Policy recommendations for a new era of leadership in global health R&D was features on the website NewsMedical.net.
View
The U.S. Congress and Biden-Harris administration have a clear opportunity to supercharge global R&D in the wake of a pandemic that has revealed both the sector’s chronic neglect and amazing potential, according to a detailed agency-by-agency action plan released today by GHTC.
Learn more